Klotho-derived peptide KP1 ameliorates SARS-CoV-2-associated acute kidney injury
Jie Xu,
No information about this author
Enqing Lin,
No information about this author
Xue Hong
No information about this author
et al.
Frontiers in Pharmacology,
Journal Year:
2024,
Volume and Issue:
14
Published: Jan. 3, 2024
Introduction:
The
severe
cases
of
COVID-19,
a
disease
caused
by
acute
respiratory
syndrome
coronavirus-2
(SARS-CoV-2),
often
present
with
kidney
injury
(AKI).
Although
old
age
and
preexisting
medical
conditions
have
been
identified
as
principal
risk
factors
for
COVID-19-associated
AKI,
the
molecular
basis
behind
such
connection
remains
unknown.
In
this
study,
we
investigated
pathogenic
role
Klotho
deficiency
in
AKI
explored
therapeutic
potential
Klotho-derived
peptide
1
(KP1).
Methods:
We
assessed
susceptibility
deficient
Kl/Kl
mice
to
developing
after
expression
SARS-CoV-2
N
protein.
KP1
ameliorating
tubular
was
using
cultured
proximal
cells
(HK-2)
vitro
mouse
model
ischemia-reperfusion
(IRI)
vivo
.
Results:
Renal
markedly
downregulated
various
chronic
(CKD)
models
aged
mice.
Compared
wild-type
counterparts,
mutant
KL/KL
were
susceptible
overexpression
protein
developed
lesions
resembling
AKI.
,
alone
induced
HK-2
express
markers
injury,
cellular
senescence,
apoptosis
epithelial-mesenchymal
transition,
whereas
both
abolished
these
lesions.
Furthermore,
mitigated
dysfunction,
alleviated
inhibited
IRI
Conclusion:
These
findings
suggest
that
is
key
determinant
As
such,
KP1,
small
recapitulating
function,
could
be
an
effective
alleviating
COVID-19
patients.
Language: Английский
In silico evidence implicating novel mechanisms of Prunella vulgaris L. as a potential botanical drug against COVID-19-associated acute kidney injury
Xue‐Ling Yang,
No information about this author
Chun-Xuan Wang,
No information about this author
Jiaxing Wang
No information about this author
et al.
Frontiers in Pharmacology,
Journal Year:
2023,
Volume and Issue:
14
Published: May 18, 2023
COVID-19-associated
acute
kidney
injury
(COVID-19
AKI)
is
an
independent
risk
factor
for
in-hospital
mortality
and
has
the
potential
to
progress
chronic
disease.
Prunella
vulgaris
L
.,
a
traditional
Chinese
herb
that
been
used
treatment
of
variety
diseases
centuries,
could
have
treat
this
complication.
In
study,
we
studied
protective
role
in
COVID-19
AKI
explored
its
specific
mechanisms
applied
by
network
pharmacology
bioinformatics
methods.
The
combination
protein-protein
interaction
Gene
Ontology
Kyoto
Encyclopedia
Genes
Genomes
enrichment
-target
gene
revealed
eight
key
target
genes
(VEGFA,
ICAM1,
IL6,
CXCL8,
IL1B,
CCL2,
IL10
RELA).
Molecular
docking
showed
all
these
gene-encoded
proteins
be
effectively
bound
three
major
active
compounds
(quercetin,
luteolin
kaempferol),
thus
becoming
therapeutic
targets.
dynamics
simulation
also
supports
binding
stability
RELA-encoded
protein
with
quercetin
luteolin.
Together,
our
data
suggest
VEGFA,
RELA
drug
targets
inhibiting
NF-κB
signaling
pathway.
Our
silico
studies
shed
new
insights
into
P.
ingredients,
e.g.,
quercetin,
as
botanical
drugs
against
AKI,
warrant
further
on
efficacy
mechanisms.
Language: Английский
Editorial on the Special Issue “Advances in Pediatric Acute Kidney Injury”
Children,
Journal Year:
2024,
Volume and Issue:
11(2), P. 195 - 195
Published: Feb. 3, 2024
Acute
kidney
injury
(AKI)
refers
to
a
swift
decline
in
function,
marked
by
the
reduced
excretion
of
waste
products
and
disturbances
fluid
electrolyte
balance
[...]
Language: Английский
Clinical Characteristics and Outcomes of Unvaccinated Kidney Transplant Recipients Infected with the SARS-CoV-2 Omicron Variant: A Case Series
Yue Qu,
No information about this author
Jing Zhuang,
No information about this author
Yanya Duan
No information about this author
et al.
Integrative Medicine in Nephrology and Andrology,
Journal Year:
2024,
Volume and Issue:
11(1)
Published: Feb. 26, 2024
ABSTRACT
Background:
Due
to
their
chronic
immunocompromised
status,
kidney
transplant
(KT)
recipients
face
escalated
risks
from
coronavirus
disease
2019
(COVID-19),
which
may
be
exacerbated
by
lower
vaccination
rates.
However,
there
is
a
paucity
of
information
regarding
the
clinical
traits
unvaccinated
KT
with
COVID-19.
We
aimed
investigate
characteristics
and
outcomes
severe
acute
respiratory
syndrome
2
(SARS-CoV-2)
Omicron
infection
in
recipients.
Methods:
In
this
retrospective
study,
we
analyzed
36
diagnosed
SARS-CoV-2
infection,
as
confirmed
reverse
transcription
polymerase
chain
reaction.
Clinical
characteristics,
laboratory
tests,
treatment
regimens,
were
examined,
2-month
follow-up
assessments
conducted.
Results:
had
high
incidence
66.7%
classified
having
severe/critical
illness.
Factors
associated
illness
included
age;
diabetes
mellitus;
lung
computed
tomography
score;
elevated
serum
D-dimer,
interleukin-6,
C-reactive
protein,
procalcitonin,
ferritin
levels.
The
patients
group
also
significantly
blood
lymphocyte
counts
albumin
Treatment
strategies
discontinuation
antimetabolic
drugs,
reduction
or
calcineurin
inhibitor
antiviral
therapy,
early
patient-tailored
nutritional
support.
Acute
injury
was
observed
19.4%
patients.
Four
(11.1%)
died
during
observation
period,
two
(5.6%)
succumbing
hospitalization
period
due
infection.
remaining
did
not
report
any
significant
symptoms
are
still
undergoing
follow-up.
Conclusion:
Early
diagnosis,
personalized
treatment,
vigilant
monitoring
all
crucial
aspects
management
These
findings
contribute
understanding
COVID-19
KT.
Language: Английский
Research on coronavirus disease 2019 and the kidney: A bibliometric analysis
Yujiao Wang,
No information about this author
Tingting Chen,
No information about this author
Chunyang Li
No information about this author
et al.
Heliyon,
Journal Year:
2024,
Volume and Issue:
10(11), P. e31749 - e31749
Published: May 25, 2024
In
addition
to
damage
the
lungs,
coronavirus
disease
2019
(COVID-19)
can
multiple
organs,
including
kidney.
Our
purpose
was
analyze
research
hotspots
and
trends
in
COVID-19
kidney
diseases
using
bibliometrics
help
clarify
development
direction
of
this
field.
Language: Английский
Clinical characteristics and outcomes of unvaccinated kidney transplant patients infected with SARS-CoV-2 omicron subvariant BA.5.2
Yue Qu,
No information about this author
Jing Zhuang,
No information about this author
Yanya Duan
No information about this author
et al.
Research Square (Research Square),
Journal Year:
2023,
Volume and Issue:
unknown
Published: July 10, 2023
Abstract
Background
Kidney
transplant
(KT)
recipients,
who
are
chronically
immunocompromised,
face
increased
risks
due
to
COVID-19
and
lower
vaccination
rates.
Limited
knowledge
exists
regarding
the
clinical
characteristics
of
unvaccinated
KT
patients
with
COVID-19.
This
study
aimed
examine
features
outcomes
infected
SARS-CoV-2
omicron
subvariant
BA.5.2.
Methods
The
enrolled
36
compared
them
20
control
cases
without
underlying
medical
conditions.
Clinical
characteristics,
laboratory
tests,
treatment
regimens,
were
analyzed.
RT-PCR
confirmed
Omicron
BA.5.2
infection.
Results
experienced
severe
disease,
66.7%
classified
as
severe/critical
illness.
Dyspnea
on
admission,
blood
leukocyte
lymphocyte
counts,
hemoglobin
levels,
serum
albumin
levels
more
prevalent
in
group
group.
Severe/critical
illness
was
associated
factors
such
age,
diabetes
mellitus,
lung
infection
CT
score,
elevated
D-dimer,
IL-6,
CRP,
Procalcitonin,
ferritin.
Blood
counts
significantly
patients.
Treatment
included
discontinuation
anti-metabolic
drugs,
reduction,
or
calcineurin
inhibitor
antiviral
therapy,
early
patient-tailored
nutritional
support.
Acute
kidney
injury
observed
19.4%
cases,
four
died
during
observation
period.
Conclusions
Early
diagnosis,
personalized
diligent
monitoring
crucial
for
These
findings
contribute
understanding
management
population.
Language: Английский
A Case of Long COVID-19 Myocarditis with Asymptomatic Manifestation in a Young Male
Galician Medical Journal,
Journal Year:
2023,
Volume and Issue:
30(3), P. E202337 - E202337
Published: Sept. 1, 2023
Background.
Myocarditis
is
one
of
the
most
dangerous
complications
both
acute
phase
COVID-19
and
long
COVID-19,
with
a
rather
heterogeneous
clinical
presentation
that
ranges
from
asymptomatic
to
life-threatening.
The
diverse
high
risk
further
complications,
on
hand,
good
prognosis
in
case
appropriate
treatment,
other
demand
great
attention
doctors.
Case
Report.
We
report
27-year-old
male
presented
cardiologist
complaints
dyspnea,
chest
pain,
palpitation
occurred
eight
months
after
mild
episode.
diagnostic
search
commenced
detailed
questioning
physical
examination
laboratory
testing
instrumental
procedures,
including
resting
electrocardiography,
two-dimensional
speckle-tracking
echocardiography,
stress
echocardiography.
Gadolinium-enhanced
cardiac
magnetic
resonance
was
final
step
diagnosis
establishment.
Half-a-year
follow-up
period
patient
manifestation
myocarditis
demonstrated
normalization
condition
prescribed
pathogenetic
treatment.
Conclusions.
This
raises
awareness
need
for
prolonged
patients
an
episode
proposes
comprehensive
approach
possible
differential
precise
treatment
young
rationale
based
relevant
literature.
Language: Английский